Pre-clinical safety and therapeutic efficacy of a plant-based alkaloid in a human colon cancer xenograft model.

MLA

Freeling, Jessica L., et al. “Pre-Clinical Safety and Therapeutic Efficacy of a Plant-Based Alkaloid in a Human Colon Cancer Xenograft Model.” Cell Death Discovery, vol. 8, no. 1, Mar. 2022, p. 135. EBSCOhost, https://doi.org/10.1038/s41420-022-00936-3.

APA

Freeling, J. L., Scholl, J. L., Eikanger, M., Knoblich, C., Potts, R. A., Anderson, D. J., Rower, J. E., Farjoo, M. H., Zhao, H., Pillatzki, A., & Rezvani, K. (2022). Pre-clinical safety and therapeutic efficacy of a plant-based alkaloid in a human colon cancer xenograft model. Cell Death Discovery, 8(1), 135. https://doi.org/10.1038/s41420-022-00936-3

Chicago

Freeling, Jessica L, Jamie L Scholl, Morgan Eikanger, Cole Knoblich, Rashaun A Potts, David J Anderson, Joseph E Rower, et al. 2022. “Pre-Clinical Safety and Therapeutic Efficacy of a Plant-Based Alkaloid in a Human Colon Cancer Xenograft Model.” Cell Death Discovery 8 (1): 135. doi:10.1038/s41420-022-00936-3.